End-of-day quote
Toronto S.E.
|
- CAD
|
-
|
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
68.5
|
24.39
|
58.58
|
40.45
|
53.18
|
49.08
|
-
|
-
|
Enterprise Value (EV)
1 |
68.5
|
24.39
|
58.58
|
40.45
|
53.18
|
81.88
|
72.18
|
49.08
|
P/E ratio
|
-
|
-2.33
x
|
14.5
x
|
-10
x
|
-
|
4.8
x
|
2.67
x
|
3
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
11
x
|
-
|
1.12
x
|
0.51
x
|
0.46
x
|
0.45
x
|
0.39
x
|
0.31
x
|
EV / Revenue
|
11
x
|
-
|
1.12
x
|
0.51
x
|
0.46
x
|
0.76
x
|
0.57
x
|
0.31
x
|
EV / EBITDA
|
-38.1
x
|
-
|
7.9
x
|
2.38
x
|
2.05
x
|
3.71
x
|
2.52
x
|
1.2
x
|
EV / FCF
|
-25.3
x
|
-
|
-
|
-
|
-
|
31.5
x
|
7.18
x
|
-
|
FCF Yield
|
-3.95%
|
-
|
-
|
-
|
-
|
3.18%
|
13.9%
|
-
|
Price to Book
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
3,42,504
|
3,48,489
|
4,03,990
|
4,04,484
|
4,09,039
|
4,09,039
|
-
|
-
|
Reference price
2 |
0.2000
|
0.0700
|
0.1450
|
0.1000
|
0.1300
|
0.1200
|
0.1200
|
0.1200
|
Announcement Date
|
25/05/20
|
14/04/21
|
22/04/22
|
24/04/23
|
29/04/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
6.2
|
-
|
52.45
|
79.33
|
116
|
108.3
|
126.4
|
157.3
|
EBITDA
1 |
-1.8
|
-
|
7.417
|
17.01
|
25.9
|
22.07
|
28.67
|
41
|
EBIT
1 |
-3.647
|
-
|
5.968
|
-0.714
|
1.412
|
4.9
|
19.7
|
-
|
Operating Margin
|
-58.82%
|
-
|
11.38%
|
-0.9%
|
1.22%
|
4.53%
|
15.59%
|
-
|
Earnings before Tax (EBT)
|
-
|
-
|
1.743
|
-4.462
|
-1.77
|
-
|
-
|
-
|
Net income
1 |
-
|
-9.21
|
1.743
|
-4.462
|
-1.77
|
9.75
|
18.6
|
-
|
Net margin
|
-
|
-
|
3.32%
|
-5.62%
|
-1.53%
|
9.01%
|
14.72%
|
-
|
EPS
2 |
-
|
-0.0300
|
0.0100
|
-0.0100
|
-
|
0.0250
|
0.0450
|
0.0400
|
Free Cash Flow
1 |
-2.704
|
-
|
-
|
-
|
-
|
2.6
|
10.05
|
-
|
FCF margin
|
-43.61%
|
-
|
-
|
-
|
-
|
2.4%
|
7.95%
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
11.78%
|
35.06%
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
26.67%
|
54.03%
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
25/05/20
|
14/04/21
|
22/04/22
|
24/04/23
|
29/04/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
13.37
|
14.02
|
16.65
|
18.56
|
18.32
|
25.8
|
27.14
|
30.89
|
30.19
|
27.73
|
23.87
|
26
|
28.43
|
29.93
|
30
|
EBITDA
1 |
2.256
|
1.45
|
2.459
|
3.23
|
4.259
|
7.061
|
6.765
|
7.302
|
6.702
|
5.136
|
4.167
|
5.2
|
6.167
|
6.533
|
6.7
|
EBIT
|
0.15
|
1.715
|
-3.382
|
-1.199
|
5.923
|
-2.055
|
0.171
|
-
|
-
|
-0.291
|
-
|
-
|
-
|
-
|
-
|
Operating Margin
|
1.12%
|
12.23%
|
-20.31%
|
-6.46%
|
32.33%
|
-7.97%
|
0.63%
|
-
|
-
|
-1.05%
|
-
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
|
-0.926
|
0.667
|
-4.372
|
-2.112
|
5.169
|
-3.147
|
-0.569
|
-
|
-
|
-1.191
|
-
|
-
|
-
|
-
|
-
|
Net income
|
-0.913
|
0.654
|
-4.372
|
-2.112
|
5.169
|
-3.147
|
-0.569
|
-
|
-
|
-1.191
|
-
|
-
|
-
|
-
|
-
|
Net margin
|
-6.83%
|
4.67%
|
-26.26%
|
-11.38%
|
28.21%
|
-12.2%
|
-2.1%
|
-
|
-
|
-4.29%
|
-
|
-
|
-
|
-
|
-
|
EPS
2 |
-
|
0.0100
|
-0.0100
|
-0.0100
|
0.0100
|
-
|
-0.001400
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
18/11/21
|
22/04/22
|
25/05/22
|
18/08/22
|
15/11/22
|
24/04/23
|
29/05/23
|
29/10/23
|
16/11/23
|
29/04/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
32.8
|
23.1
|
-
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
1.486
x
|
0.8058
x
|
-
|
Free Cash Flow
1 |
-2.7
|
-
|
-
|
-
|
-
|
2.6
|
10.1
|
-
|
ROE (net income / shareholders' equity)
|
-
|
-
|
-
|
-
|
-
|
12.8%
|
13.9%
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
5.1%
|
6.5%
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
191.2
|
286.2
|
-
|
Book Value Per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
1.26
|
-
|
-
|
-
|
-
|
2
|
3.5
|
-
|
Capex / Sales
|
20.32%
|
-
|
-
|
-
|
-
|
1.85%
|
2.77%
|
-
|
Announcement Date
|
25/05/20
|
14/04/21
|
22/04/22
|
24/04/23
|
29/04/24
|
-
|
-
|
-
|
Last Close Price
0.12
CAD Average target price
0.3833
CAD Spread / Average Target +219.44% Consensus |
1st Jan change
|
Capi.
|
---|
| +40.09% | 6.16B | | -16.34% | 4.46B | | -7.11% | 3.27B | | +5.14% | 3.2B | | -0.18% | 2.6B | | +47.93% | 1.98B | | -7.15% | 1.7B | | +0.67% | 1.66B | | -8.73% | 1.61B |
Alternative Medicine
|